Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COTRIM-HIGH cotrimoxazole prophylaxis after kidney transplantation
2026-526183-20-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trimethoprim + sulfamethoxazole in bacterial disease (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Occurrence of any bacterial infection. Planned start Oct 2026; status: authorised.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2026-526183-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526183-20-00.